Arecor Therapeutics plc announced that, due to its auditor, Grant Thornton UK LLP, requiring additional time to complete its standard procedures, the Group's final results for the year ended 31 December 2023 will not be published on 7 May 2024, the previously planned date. The Group will now announce its results in the week commencing 13 May 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131 GBX | 0.00% | -4.03% | -28.22% |
05-16 | EARNINGS AND TRADING: Michelmersh continues with positive order intake | AN |
05-16 | Transcript : Arecor Therapeutics plc, 2023 Earnings Call, May 16, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.22% | 50.84M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- AREC Stock
- News Arecor Therapeutics plc
- Arecor Therapeutics plc Announces Delay in Publication of the Group's Final Results for the Year Ended 31 December 2023